Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERS●NASDAQ
HealthcareMedical - Devices
$2.59
$0.02(0.78%)
U.S. Market opens in 57h 42m

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap521.9M
P/E Ratio-71.13
EPS (TTM)$-0.05
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$2.76
3 Months$3.32
1 Year Target$3.26

CERS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cerus Corporation (NASDAQ: CERS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cerus Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CERS on the NASDAQ shows an RSI of 42.13, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.26 for the NASDAQ listing.

Key metrics behind Cerus Corporation's NASDAQ-traded stock include a P/E ratio of -71.13 and a market capitalization of 521.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CERS on the NASDAQ.

Price Performance (NASDAQ: CERS)

1-Day Change
0.78%
5-Day Change
-4.07%
1-Month Change
18.26%
3-Month Change
-7.17%
6-Month Change
15.63%
Year-to-Date (YTD) Change
25.73%
1-Year Change
94.74%
3-Year Change
48.00%
5-Year Change
-59.47%
All-Time (Max) Change
-78.64%

Contact Information

https://www.cerus.com
925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

2,680 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions